[1] 周梦龙, 王亚农. 进展期胃癌及胃食管结合部腺癌术前同期放化疗的临床研究进展[J].中国癌症杂志, 2013, 23(10):852-856. [2] Shoji T , Takatori E , Furutake Y,et al. Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass[J].Int J Clin Oncl,2016, 21(6):1120-1127. [3] 阎婷婷.浅谈对实施胃癌根治术的患者进行同期放化疗的临床效果[J].当代医药论丛,2014,18(20):252. [4] 陈志平,潘群雄,许荣誉,等.术前同期放化疗对胃癌患者颗粒蛋白前体表达及肿瘤组织细胞活性的影响[J].中华胃肠外科杂志,2017,20(4):464-467. [5] 张亮,王小博,张磊,等.局部进展期胃癌术后放化疗与单纯化疗的临床对比研究[J].实用临床医药杂志,2015,19(23):139-140,145. [6] 尹继磊,刘峥,李海燕,等.进展期胃癌术后三维适形放疗联合同期XELOX化疗临床观察[J].河北医药,2013,35(14):2108-2110. [7] 李彦良,孙现军,宋希林,等.进展期胃癌术后调强放射疗法联合同期口服替吉奥化学疗法耐受性研究[J].中华消化杂志,2014,34(08):550-552. [8] Watanabe SI,Nakagawa K,Suzuki K ,et al.Neoadjuvant and adjuvant therapy for Stage Ⅲ non-small cell lung cancer[J].Jpn J Clin Oncl,2017, 47(12):1112-1118.
2018, Vol. 35 
